Latest Biotech News

University of Michigan researchers conducted first quantum-mechanical simulations of quasicrystals, showing that these non-repeating atomic structures can be energetically stable. Employing...

Researchers reported a novel approach to generate functional vascular organoids by simultaneous activation of endothelial and mural lineage transcription factors ETV2 and NKX3.1. This method...

Two studies highlight advances in Parkinson’s research: one identifies perivascular fluid diffusivity as an early clinical progression biomarker using advanced MRI, enabling prognosis prior to...

The integration of proteomics with DNA sequencing technologies is accelerating multiomics approaches in biological research. Collaborations between Ultima Genomics and Olink Proteomics, as well as...

Notable FDA news includes approval of Moderna’s RSV vaccine expansion to at-risk younger adults and Medtronic’s clearance of a miniature defibrillation lead for pediatric use. Additionally,...

Innovations in artificial intelligence are reshaping scientific communication and drug discovery. AI-generated podcasts are effectively summarizing complex cardiovascular nursing research, gaining...

The FDA approved pembrolizumab for patients with resectable locally advanced head and neck squamous cell carcinoma expressing PD-L1, marking the first checkpoint inhibitor approval in this...

Anne Wojcicki’s nonprofit TTAM Research Institute secured 23andMe’s assets in a $305 million deal, outbidding Regeneron and committing to stringent privacy protections and continued data use for...

After discontinuing its only clinical-stage candidate, ADC Therapeutics announced the closure of its UK R&D site and a 30% workforce reduction. The restructuring focuses resources on approved...

The FDA has approved pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma patients with PD-L1 expression, based on the KEYNOTE-689 Phase 3 trial demonstrating...

A bidding war for 23andMe culminated with former CEO Anne Wojcicki’s nonprofit, TTAM Research Institute, winning the auction with a $305 million offer that surpasses Regeneron’s $256 million bid....

New Parkinson’s disease research highlights drug repurposing opportunities through integrative multi-omics analysis revealing memory-enhancing effects of meclofenoxate hydrochloride. Studies...

A recent early-phase trial combining revumenib, a menin inhibitor, with established AML treatments showed promising remission rates in genetically defined acute myeloid leukemia patients, leading...

An international collaboration achieved the most extensive simultaneous comparison of optical atomic clocks across six countries, paving the way to redefine the second and enabling new...

Researchers at the Technical University of Munich demonstrated that artificial neural networks pretrained using biological data from early visual system development in mice outperform models...

Engineers at UC San Diego unveiled an evaporative cooling technology utilizing porous fiber membranes that passively dissipate heat, aiming to drastically improve data center energy efficiency and...

Pending U.S. legislative proposals include important biotechnology provisions such as the ORPHAN Cures Act, which addresses rare disease drug pricing and aims to restore incentives for developing...

Recent comprehensive reviews outline the pathogenic role of Fusobacterium nucleatum in colorectal cancer, including its influence on tumor initiation, progression, metastasis and resistance to...

A novel method developed by Boston Children's Hospital and Harvard Medical School allows the rapid creation of functional vascular organoids from human stem cells by co-activating endothelial and...

Key provisions in the US budget bill under Senate consideration aim to reshape biopharma innovation and pricing. The package proposes reforms to the Inflation Reduction Act's orphan drug...